Skip to main content
. 2022 Feb 20;11(4):1121. doi: 10.3390/jcm11041121

Table 1.

Baseline demographics of the methylene blue group compared to control group and propensity score-matched control group.

Methylene Blue
N = 60
Control
N = 759
p-Value Matched Control
N = 60
p-Value
Male sex 51 85.0 580 76.4 0.082 44 73.3 0.177
Age (y) 62.3 ±12.2 64.0 ±13.6 0.351 62.0 ±14.2 0.891
BMI (kg/m2) 27.5 ±4.5 26.2 ±4.3 0.024 26.7 ±4.8 0.363
ASA class 0.062 0.414
1 0 0 1 0.1 0 0.0
2 0 0 1 0.1 0 0.0
3 12 20.0 293 38.6 10 16.7
4 42 70.0 419 55.2 39 65.0
5 6 10.0 45 5.9 11 18.3
Procedure <0.001 0.031
Aorta 16 26.7 107 14.1 7 11.7
Valve 21 35.0 302 39.8 20 33.3
Bypass 8 13.3 225 29.6 18 30.0
Artificial heart 5 8.3 69 9.1 9 15.0
Combination 4 6.7 22 2.9 0 0.0
Other 2 3.3 25 3.3 4 6.7
Revision 4 6.7 9 1.2 2 3.3
Emergency 13 21.7 151 19.9 0.738 16 26.7 0.335

Perioperative variables are shown regarding the use of MB versus standard therapy (matched control), indicating mean or percentage, respectively. This table also shows the results compared to the overall collective before matching. p-values indicate significance versus “methylene blue” group. BMI: Body mass index; ASA: American Society of Anesthesiologists.